A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)
Clinical trial NCT07743671 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07743671
- Sponsor
- Vaderis Therapeutics AG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.